Literature DB >> 15063229

Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.

Omar A Khan1, James J Fitzgerald, Mark L Field, Irshad Soomro, F David Beggs, W Ellis Morgan, John P Duffy.   

Abstract

BACKGROUND: The histologic determinants of survival after surgical resection of stage II nonsmall cell lung cancer are poorly understood. We analyzed the prognostic significance of a number of histologic features after complete resection of T1-2N1M0 nonsmall cell cancer of the lung.
METHODS: The case notes and histology of all patients who underwent a potentially curative surgical resection for T1-2N1M0 nonsmall cell carcinoma of the lung between 1991 and 1997 were reviewed retrospectively. The following histologic factors were recorded: histologic type of tumor; number of nodes with metastatic deposits together with their nodal station; the presence of vascular invasion, visceral pleural involvement, and cellular necrosis; and grade of tumor. The results from 98 patients were analyzed. Univariate and multivariate analyses were performed to identify prognostic factors.
RESULTS: Univariate analysis showed that only three factors had a statistically significant correlation with a poor prognosis: vascular invasion (p = 0.002), nonsquamous histology (p = 0.005), and visceral pleural involvement (p = 0.002). Multivariate analysis revealed that all three factors were significant independent adverse prognostic indicators.
CONCLUSIONS: Visceral pleural involvement, nonsquamous histology, and vascular invasion are all significant adverse prognostic factors after surgical resection of T1-2N1M0 nonsmall cell cancer of the lung. These findings conflict with previously published reports, and we advocate a prospective, large-scale study in order to clarify the prognostic significance of histologic characteristics in stage II disease.

Entities:  

Mesh:

Year:  2004        PMID: 15063229     DOI: 10.1016/j.athoracsur.2003.08.080

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer.

Authors:  Juan P Wisnivesky; Jacqueline Arciniega; Grace Mhango; John Mandeli; Ethan A Halm
Journal:  Thorax       Date:  2010-12-02       Impact factor: 9.139

2.  How close are we to customizing chemotherapy in early non-small cell lung cancer?

Authors:  Georgios Ioannidis; Vassilis Georgoulias; John Souglakos
Journal:  Ther Adv Med Oncol       Date:  2011-07       Impact factor: 8.168

3.  Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung.

Authors:  Tetsuya Isaka; Haruhiko Nakayama; Tomoyuki Yokose; Hiroyuki Ito; Kayoko Katayama; Kouzo Yamada; Munetaka Masuda
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-12-27       Impact factor: 1.520

4.  A histochemical approach to the diagnosis of visceral pleural infiltration by non-small cell lung cancer.

Authors:  Arne Warth; Thomas Muley; Esther Herpel; Joachim Pfannschmidt; Hans Hoffmann; Hendrik Dienemann; Peter Schirmacher; Philipp A Schnabel
Journal:  Pathol Oncol Res       Date:  2010-03       Impact factor: 3.201

Review 5.  Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Jun Wang; Jianpeng Chen; Xi Chen; Baocheng Wang; Kainan Li; Jingwang Bi
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 6.  Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review.

Authors:  Charalampos Gkogkou; Konstantina Frangia; Muhammad W Saif; Rodoula Trigidou; Konstantinos Syrigos
Journal:  Springerplus       Date:  2014-03-01

7.  Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection.

Authors:  Dai Sonoda; Yosuke Matsuura; Junji Ichinose; Masayuki Nakao; Hironori Ninomiya; Mingyon Mun; Yuichi Ishikawa; Ken Nakagawa; Yukitoshi Satoh; Sakae Okumura
Journal:  Cancer Manag Res       Date:  2019-07-19       Impact factor: 3.989

8.  Predicting recurrence using the clinical factors of patients with non-small cell lung cancer after curative resection.

Authors:  Hyun Joo Lee; Jisuk Jo; Dae-Soon Son; Jinseon Lee; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Jhingook Kim
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

9.  Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients.

Authors:  Chia-Hsin Liu; Yi-Jen Peng; Hong-Hau Wang; Ying-Chieh Chen; Chen-Liang Tsai; Chih-Feng Chian; Tsai-Wang Huang
Journal:  Thorac Cancer       Date:  2015-02-27       Impact factor: 3.500

10.  Identifying survival associated morphological features of triple negative breast cancer using multiple datasets.

Authors:  Chao Wang; Thierry Pécot; Debra L Zynger; Raghu Machiraju; Charles L Shapiro; Kun Huang
Journal:  J Am Med Inform Assoc       Date:  2013-04-12       Impact factor: 4.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.